Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.
Fraaij PL, van der Vries E, Beersma MF, Riezebos-Brilman A, Niesters HG, van der Eijk AA, de Jong MD, Reis Miranda D, Horrevorts AM, Ridwan BU, Wolfhagen MJ, Houmes RJ, van Dissel JT, Fouchier RA, Kroes AC, Koopmans MP, Osterhaus AD, Boucher CA.
Fraaij PL, et al. Among authors: beersma mf.
J Infect Dis. 2011 Sep 1;204(5):777-82. doi: 10.1093/infdis/jir397.
J Infect Dis. 2011.
PMID: 21844304
Free PMC article.